PR Newswire·Nov 9, 2026, 4:05 PM ET

NHI Announces Third Quarter 2026 Results

NHI

National Health Investors, Inc. reported net income of $11.47 per diluted share for the quarter ended September 30, 2026, compared to $0.69 per share in the prior year.
Net income for the nine months ended September 30, 2026, was $13.52 per diluted share, up from $2.22 per share in the same period last year.
The company recognized a $541.6 million gain on the sale of the National Healthcare Corporation leased portfolio completed on July 1, 2026.
NAREIT Funds from Operations per diluted share increased 2.8% to $1.12 for the quarter and 3.5% to $3.54 for the nine months ended September 30, 2026.
Normalized FFO per diluted share decreased 15.2% to $1.12 for the quarter and 4.1% to $3.54 for the nine months ended September 30, 2026.
Normalized Funds Available for Distribution decreased $5.1 million to $57.1 million for the quarter but increased $7.0 million to $181.2 million for the nine months ended September 30, 2026.
The company closed over $395 million in investments year-to-date and expects to complete additional significant investments before year-end.
Portfolio activity included the sale of 35 properties to NHC in July 2026, the sale of two skilled nursing facilities in Texas in July 2026, and the acquisition of six senior housing communities in October 2026.
Additional acquisitions in October 2026 included an assisted living facility in Michigan for $16.8 million and an inpatient rehabilitation hospital in Florida for $34.6 million.
The company sold an assisted living facility in Illinois in November 2026, following a $9.9 million impairment charge recognized in the third quarter.
As of September 30, 2026, the company had $1.0 billion in consolidated net debt and maintained a net debt to annualized adjusted EBITDA ratio of 3.6x.
The board declared a $0.94 per share dividend payable on January 29, 2027, to common stockholders of record as of December 31, 2026.
Full-year 2026 guidance projects NAREIT FFO per diluted share between $4.68 and $4.70, with Normalized FFO per diluted share in the same range.
The company has approximately $285.3 million in signed Letters of Intent and an additional $400 million pipeline of investment opportunities.
$500.0 million remains available under the company's ATM equity program following the renewal of its shelf registration statement in March 2026.

Company: National Health Investors, Inc.
Keywords: National Health Investors, Inc.